<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04959604</url>
  </required_header>
  <id_info>
    <org_study_id>CCLNM</org_study_id>
    <nct_id>NCT04959604</nct_id>
  </id_info>
  <brief_title>Lymph Node Mapping Via Flourescent Dye in Colon Cancer</brief_title>
  <official_title>Lymph Node Mapping Via the Flourescent Dye ICG in Colon Cancer Through Preoperative Application</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitätsklinikum Hamburg-Eppendorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitätsklinikum Hamburg-Eppendorf</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to evaluate whether lymph nodes draining the region of the carcinoma&#xD;
      are located only inside the lines of standard resection or in some percentages are located&#xD;
      outside as well. The visualized nodes draining the region of the carcinoma will be correlated&#xD;
      to location, fluorescent yes/no and nodal positive/negative.&#xD;
&#xD;
      The draining lymph nodes will be visualized using the fluorescent dye indocyanine green.&#xD;
&#xD;
      The aim of the study is to evaluate whether lymph nodes draining the region of the carcinoma&#xD;
      are located only inside the lines of standard resection or in some percentages are located&#xD;
      outside as well. The visualized nodes draining the region of the carcinoma will be correlated&#xD;
      to location, fluorescent yes/no and nodal positive/negative.&#xD;
&#xD;
      The draining lymph nodes will be visualized using the fluorescent dye indocyanine green.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants with a diagnosed (andeno)carcinoma of the ascending, transverse, descending and&#xD;
      sigmoid colon will be included. Preoperatively the participants will receive an indocyanine&#xD;
      green(ICG) injection at four points around the tumour endoscopically. The ICG marking will&#xD;
      take place one to five days prior to surgery. In the draining lymph nodes of the specific&#xD;
      region the ICG will accumulate and thus visible via fluorescence-camera during the surgery.&#xD;
&#xD;
      Intraoperatively, the precise locations of all fluorescent nodes will be documented&#xD;
      photographically. A standard resection and lymph node dissection will be conducted, potential&#xD;
      fluorescent nodes outside the standard resection lines will additionally be resected. The&#xD;
      fresh specimen will then be measured, the fluorescent nodes marked and after the pathologic&#xD;
      examination the nodes will be correlated to location, fluorescent yes/no and nodal&#xD;
      positive/negative.&#xD;
&#xD;
      The aim ist not the visualization of the Sentinel node or the directly draining lymphatic&#xD;
      vessel but all the nodes draining the peritumorous region at the point of surgery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 31, 2021</start_date>
  <completion_date type="Anticipated">June 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Intervention group. Participants will receive a state of the art surgical procedure with additional lymph node mapping</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Intraoperative ICG-positive lymph nodes in vivo after endoscopic marking of the tumour</measure>
    <time_frame>intraoperative assessment</time_frame>
    <description>Counting ICG-positive sites intraoperatively</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Video-analysis of ICG-positive lymph nodes in vivo after endoscopic marking of the tumour</measure>
    <time_frame>video-analysis within one week after surgery</time_frame>
    <description>Counting ICG-positive sites video-analysis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of ICG-positive lymph nodes after endoscopic marking of the tumour</measure>
    <time_frame>within one week after surgery</time_frame>
    <description>Picking ICG-positive lymph nodes ex vivo in unfixed specimen, sending ICG positive nodes separately to pathological examination</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Correlation of nodal-positive lymph nodes inside/outside the standard resection area</measure>
    <time_frame>within one week after surgery</time_frame>
    <description>ICG-positive sites outside standard resection area will be &quot;cherry picked&quot;, sent to pathological examination separatively.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Colon Carcinoma</condition>
  <condition>Lymph Node Metastases</condition>
  <arm_group>
    <arm_group_label>ICG-marked Colon Carcinoma</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The participants will receive an endoscopic marking via ICG preoperatively</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ICG-marking endoscopically</intervention_name>
    <description>Preoperatively the participants will receive an endoscopic marking at four points around the tumour with the fluorescent dye indocyanine green.</description>
    <arm_group_label>ICG-marked Colon Carcinoma</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  histologically diagnosed carcinoma of the ascending, transverse, descending or sigmoid&#xD;
             colon.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  not wanting to participate&#xD;
&#xD;
          -  other carcinoma then adenocarcinoma&#xD;
&#xD;
          -  endoscopic marking not possible&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniel Perez, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept of General Visceral and Thoracic Surgery</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Katharina L Lucas, MD</last_name>
    <phone>+4915779600815</phone>
    <email>katharina.lucas@uni-wh.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Julia-Kristin Grass, Dr.</last_name>
    <phone>+4915222815011</phone>
    <email>j.grass@uke.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Hamburg Medical Institutions</name>
      <address>
        <city>Hamburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julia-Kristin Grass, Dr.</last_name>
      <email>j.grass@uke.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>June 30, 2021</study_first_submitted>
  <study_first_submitted_qc>July 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 13, 2021</study_first_posted>
  <last_update_submitted>July 10, 2021</last_update_submitted>
  <last_update_submitted_qc>July 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>indocyanine green</keyword>
  <keyword>lymphatic mapping</keyword>
  <keyword>fluorescence</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lymphatic Metastasis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Available on reasonable request</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

